Cashman Christopher Michael 4/A
4/A · MARINUS PHARMACEUTICALS INC · Filed Jan 22, 2018
Insider Transaction Report
Form 4/AAmended
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Award
Common stock
2016-08-03+56,100→ 196,869 total
Footnotes (1)
- [F1]Represents restricted common stock. All shares of restricted common stock vest on 8/3/17. This amendment is being filed to correct the reporting of restricted stock grants moving the report of grant of the restricted stock from Table II to Table I of the report being amended.